Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,700.00
-30.00 (-0.39%)
At close: Jul 11, 2025, 3:30 PM KST
-25.10%
Market Cap110.04B
Revenue (ttm)205.78B
Net Income (ttm)12.83B
Shares Out14.04M
EPS (ttm)914.02
PE Ratio8.58
Forward PEn/a
Dividend100.00 (1.30%)
Ex-Dividend DateDec 27, 2024
Volume36,966
Average Volume136,927
Open7,730.00
Previous Close7,730.00
Day's Range7,640.00 - 7,770.00
52-Week Range6,180.00 - 11,700.00
Beta0.50
RSI61.73
Earnings DateSep 1, 2025

About Daehan Nupharm

Daehan Nupharm Co.,Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers pharmaceuticals drugs for cardiovascular, endocrine system, neuropsychiatric, gastrointestinal, respiratory system, antipyretic, analgesic, anti-inflammatory, anti-infective, musculoskeletal, osteoporosis, anti-cancer, urogenital system, antifungal, antiviral, hormones, dermatologic, central nervous system, anticonvulsive, amino acid, anesthetic, antiobesity, and others; vitamins; and inorganic products. The compa... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 228
Stock Exchange KOSDAQ
Ticker Symbol 054670
Full Company Profile

Financial Performance

In 2024, Daehan Nupharm's revenue was 202.19 billion, a decrease of -1.00% compared to the previous year's 204.22 billion. Earnings were 15.47 billion, an increase of 23.33%.

Financial Statements

News

There is no news available yet.